{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:31:37Z","timestamp":1794241897682,"version":"4.9.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Takeda Development Center Asia, Pte. Limited","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Leuprorelin is an analog of gonadotropin-releasing hormone that is used for the therapy of central precocious puberty (CPP). The aims of this prospective, open label, multicenter clinical trial were to establish its efficacy and safety during long-term use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients, who were all children, were treated with 1.88 to 3.75\u200amg leuprorelin subcutaneously once every 4\u200aweeks for a total of 96\u200aweeks between 2015 and 2018. The primary endpoint was the rate of occurrence of adverse events (AEs) and the secondary endpoint was no progression in the Tanner stage or regression by week 96 compared to baseline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 307 CPP patients, 305 (99.3%) females and 2 males (0.7%), completed the 96-weeks of treatment. Due to limited data for male patients, they are not discussed in the efficacy results. Treatment-emergent AEs (TEAEs) were reported for 252 (82.1%) patients, mostly (79.5%) being mild or moderate and only 33 (10.7%) of patients experienced TEAEs related to leuprorelin therapy. The most frequent (&gt;2%) drug-related TEAEs were injection site induration (4.6%, 14\/307) and vaginal bleeding (2.3%, 7\/305). After treatment, 83.5% of patients had regression or no progression in the Tanner stage (95% confidence interval: 78.68%, 87.62%) and the majority had decreased gonadotropin-releasing hormone-stimulated peak luteinizing hormone and follicle-stimulating hormone concentrations, as well as reduced sex hormone concentrations and a reduction in the bone age\/chronological age ratio compared to baseline.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The trial revealed that CPP was effectively treated in most patients who received leuprorelin for nearly 2 years. Any drug-related AEs were reported with low incidence (&lt;5%) and were consistent with the known safety profile of leuprorelin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration:<\/jats:title>\n            <jats:p>The trial was registered at ClinicalTrials.gov (registration number: NCT02427958).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028158","type":"journal-article","created":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T19:28:33Z","timestamp":1640287713000},"page":"e28158","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-4817","authenticated-orcid":false,"given":"Xiaoping","family":"Luo","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Child Healthcare, Hunan Children's Hospital, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"You","sequence":"additional","affiliation":[{"name":"Department of Child Healthcare, Hunan Children's Hospital, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Genetics, The Affiliated Children's Hospital of Nanchang University, Jiangxi Provincial Children's Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Genetics, The Affiliated Children's Hospital of Nanchang University, Jiangxi Provincial Children's Hospital, Nanchang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Pediatric Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute for Pediatric Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Children's Hospital of Capital Institute of Pediatrics, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Children's Hospital of Capital Institute of Pediatrics, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Genetics, Children's Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqian","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Genetics, Children's Hospital of Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jiangsu Province Hospital, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangjian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Affiliated Hospital of Jiangnan University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, The First Bethune Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, The First Bethune Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Wang","sequence":"additional","affiliation":[{"name":"Takeda Development Center Asia, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Takeda Medical Affairs, Takeda (China) International Trading Co., Ltd, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,23]]},"reference":[{"key":"R1-20250504","first-page":"412","article-title":"Consensus on diagnosis and treatment of central precocious puberty","volume":"53","year":"2015","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0889-8529(18)30287-1","article-title":"The treatment of precocious puberty","volume":"20","author":"Wheeler","year":"1991","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R5-20250504","first-page":"640","article-title":"Investigation and research about precocious puberty in eastern coast of Zhejiang Province","volume":"19","author":"Lin","year":"2004","journal-title":"Shiyong Erke Linchuan Zazhi"},{"key":"R6-20250504","first-page":"497","article-title":"Progress of precocious puberty in children","volume":"20","author":"Cai","year":"2005","journal-title":"J Appl Clin Pediatr"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.beem.2018.05.008","article-title":"Central precocious puberty: from genetics to treatment","volume":"32","author":"Aguirre","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1159\/000491103","article-title":"Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty","volume":"90","author":"Kaplowitz","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"497","DOI":"10.23736\/S0026-4784.18.04316-2","article-title":"Gonadotropin-releasing hormone analog therapeutics","volume":"70","author":"Newton","year":"2018","journal-title":"Minerva Ginecol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/14656566.2013.806489","article-title":"Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties","volume":"14","author":"Bertelloni","year":"2013","journal-title":"Expert Opin Pharmacother"},{"issue":"(Suppl 1)","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1530\/EJE-08-0814","article-title":"The use of GnRH agonists in precocious puberty","volume":"159","author":"Mul","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"88951","DOI":"10.18632\/oncotarget.21627","article-title":"Proteome-based identification of apolipoprotein A-IV as an early diagnostic biomarker in liver fibrosis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"41289","DOI":"10.1038\/srep41289","article-title":"ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt signaling","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"R15-20250504","first-page":"85","article-title":"Evaluation of the dosage of LHRH analog in children with central precocious puberty","volume":"16","author":"Tanka","year":"2010","journal-title":"J Jpn Ass Hum Auxo"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"247386","DOI":"10.1155\/2015\/247386","article-title":"Evaluating the efficacy of treatment with a GnRH analogue in patients with central precocious puberty","volume":"2015","author":"Kendirci","year":"2015","journal-title":"Int J Endocrinol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1556\/OH.2012.29320","article-title":"Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty","volume":"153","author":"Sagodi","year":"2012","journal-title":"Orv Hetil"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2014.40","article-title":"Pros and cons of GnRHa treatment for early puberty in girls","volume":"10","author":"Willemsen","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"(Suppl 1)","key":"R24-20250504","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1530\/eje.0.151s047","article-title":"Bone development during GH and GnRH analog treatment","volume":"151","author":"Antoniazzi","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0022-3476(05)81720-2","article-title":"Local reactions to depot leuprolide therapy for central precocious puberty","volume":"123","author":"Manasco","year":"1993","journal-title":"J Pediatr"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(05)81162-X","article-title":"Two-year results of treatment with depot leuprolide acetate for central precocious puberty","volume":"121","author":"Neely","year":"1992","journal-title":"J Pediatr"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:08:35Z","timestamp":1746338915000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,23]]},"references-count":24,"journal-issue":{"issue":"51","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028158","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,23]]},"assertion":[{"value":"2021-03-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}